Ebglyss Injection, Solution
Product Images NDC 0002-7797
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Ebglyss (NDC 0002-7797). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Ebglyss Ai Ifu 2 V1)
Figure (Ebglyss Ai Ifu 3 V1)
Figure (Ebglyss Ai Ifu 4 V1)
Figure (Ebglyss Ai Ifu 5 V1)
Figure (Ebglyss Ai Ifu 6 V1)
Figure (Ebglyss Ai Ifu 7 V1)
Figure (Ebglyss Ai Ifu 8 V1)
Figure (Ebglyss Ai Ifu 9 V1)
Figure (Ebglyss Ai Lock)
Figure (Ebglyss Ai Unlock)
Figure (Ebglyss Ifu Inj Sites 1 V1)
Figure (Ebglyss Ifu Inj Sites 2 V1)
Carton Image Placeholder (Ebglyss Pen Carton 084 00)
Carton Image Placeholder (Ebglyss Pfs Carton 9996 02)
Figure (Ebglyss Pfs Ifu 1 V1)
Figure (Ebglyss Pfs Ifu 10 V1)
Figure (Ebglyss Pfs Ifu 2 V1)
This text provides a description of the parts of a syringe that should be checked before use. It includes information on the plunger rod, finger grips, syringe label and expiration date, viewing window, syringe body, and needle cap. Additionally, it mentions the needle after removing the needle cap.*
Figure (Ebglyss Pfs Ifu 3 V1)
Figure (Ebglyss Pfs Ifu 4 V1)
Figure (Ebglyss Pfs Ifu 5 V1)
Figure (Ebglyss Pfs Ifu 6 V1)
Figure (Ebglyss Pfs Ifu 7 V1)
Figure (Ebglyss Pfs Ifu 8 V1)
Figure (Ebglyss Pfs Ifu 9 V1)
Figure 1 (Ebglyss Uspi 1 V1)
This is a tabulated data showing the proportion of subjects in two studies: ADvocate 1 and ADvocate 2, comparing the use of EBGLYSS 250mg Q2W versus Placebo. In ADvocate 1, there were 283 subjects in the EBGLYSS group and 141 subjects in the Placebo group. In ADvocate 2, there were 281 subjects in the EBGLYSS group and 146 subjects in the Placebo group. The data is presented as a percentage table.*
Figure 2 (Ebglyss Uspi 2 V1)
Figure (Qr V1)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.